Title:
USE OF JUN INHIBITOR IN PREPARING MEDICAMENT FOR TREATING HEART FAILURE WITH PRESERVED EJECTION FRACTION
Document Type and Number:
WIPO Patent Application WO/2024/027593
Kind Code:
A1
Abstract:
The present invention relates to use of a Jun inhibitor in preparing a medicament for treating heart failure with preserved ejection fraction (HFpEF).
Inventors:
WANG LI (CN)
LI ZHENG (CN)
LI ZHENG (CN)
Application Number:
PCT/CN2023/109846
Publication Date:
February 08, 2024
Filing Date:
July 28, 2023
Export Citation:
Assignee:
FUWAI HOSPITAL CAMS (CN)
International Classes:
A61K45/00; A61K31/202; A61K31/42; A61K31/498; A61K31/4985; A61K31/519; A61K38/08; A61K38/16; A61P9/04
Domestic Patent References:
| WO2018169742A1 | 2018-09-20 |
Foreign References:
| JP2020189828A | 2020-11-26 |
Other References:
SAKAMURI SIVA S.V.P., VALENTE ANTHONY J., SIDDESHA JALAHALLI M., DELAFONTAINE PATRICE, SIEBENLIST ULRICH, GARDNER JASON D., BYSANI: "TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis", MOLECULAR AND CELLULAR ENDOCRINOLOGY, ELSEVIER IRELAND LTD, IE, vol. 429, 1 July 2016 (2016-07-01), IE , pages 84 - 92, XP093135237, ISSN: 0303-7207, DOI: 10.1016/j.mce.2016.03.038
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF: